Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:01 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1297–1320 of 121,474 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Age-related Cognitive Decline
Interventions: Computerized Plasticity-Based Adaptive Cognitive Training, Commercially available computerized training; Other
Lead sponsor: Posit Science Corporation; Industry
Eligibility: 65 Years and older
Enrollment: 147 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 2
States / cities: Iowa City, Iowa • Dallas, Texas

Conditions: Stroke
Interventions: Cognitive-Oriented Strategy Augmented Rehabilitation (COSTAR), Task Specific Training (TST); Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Epilepsy, Neurologic Manifestations
Interventions: intraoperative infrared (IR) neuroimaging; Device
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2000
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cancer Survivor, Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Lymphoma, Psychosocial Effects of Cancer and Its Treatment
Interventions: educational intervention, psychosocial assessment and care; Other · Procedure
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 6 Years to 16 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Duarte, California

Conditions: Neuropathic Pain
Interventions: BIIB074; Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Healthy
Interventions: Blood drawn from indwelling catheters versus direct venipuncture; Drug
Lead sponsor: Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Papillary Thyroid Cancer
Interventions: Radiofrequency Ablation; Procedure
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Overweight and Obesity
Interventions: ACHIEVE Intervention, Control; Behavioral · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 291 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: COVID-19, Long COVID
Interventions: MouthLabTM; Device
Lead sponsor: Edith Nourse Rogers Memorial Veterans Hospital; Federal
Eligibility: 18 Years and older
Enrollment: 204 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Bedford, Massachusetts

Conditions: Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Interventions: Blinatumomab, Pembrolizumab; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 3
States / cities: La Jolla, California • Charleston, South Carolina • Greenville, South Carolina

Conditions: Sleep Disturbances Associated With Menopause
Interventions: Elinzanetant, Placebo; Drug · Other
Lead sponsor: Bayer; Industry
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 22
States / cities: Little Port Walter, Alaska • Scottsdale, Arizona • Encinitas, California + 17 more

Conditions: Retinopathy of Prematurity
Interventions: Goggles, Ambient Light Reduction; Device · Procedure
Lead sponsor: National Eye Institute (NEI); NIH
Eligibility: Up to 1 Day
Timeline: Started 1995
U.S. locations: 3
States / cities: Buffalo, New York • Dallas, Texas • San Antonio, Texas

Conditions: Well-being
Interventions: Happify; Behavioral
Lead sponsor: Happify Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 14,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Liver Transplant Recipients
Interventions: Behavioral Telehealth; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer
Interventions: Trastuzumab, Bevacizumab, Docetaxel; Drug
Lead sponsor: Bhuvaneswari Ramaswamy; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2017
U.S. locations: 3
States / cities: Cleveland, Ohio • Columbus, Ohio • Pittsburgh, Pennsylvania

Conditions: Cystic Fibrosis
Interventions: LUM/IVA; Drug
Lead sponsor: Vertex Pharmaceuticals Incorporated; Industry
Eligibility: 6 Years and older
Enrollment: 246 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 37
States / cities: Birmingham, Alabama • Tucson, Arizona • Long Beach, California + 34 more

Conditions: Chronic Hepatitis C, Fibrosis, Hemolytic Anemia
Interventions: Ribavirin; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Type 2 Diabetes
Interventions: screening tool; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 95 Years
Enrollment: 64 participants
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Minneapolis, Minnesota

Conditions: Posttraumatic Stress Disorder, PTSD
Interventions: D-cycloserine, Placebo pill, CBT; Drug · Behavioral
Lead sponsor: Tulane University School of Medicine; Other
Eligibility: 13 Years to 18 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Homelessness
Interventions: Critical Time Intervention (CTI), External Facilitation, Replicating Effective Programs; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 192 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: West Los Angeles, California

Conditions: Major Depressive Disorder
Interventions: Iloperidone, Placebo; Drug
Lead sponsor: Maurizio Fava, MD; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hearing Loss, Aging
Interventions: Clinic-based audiological rehabilitative service delivery, Telehealth audiological rehabilitative service delivery; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 73 Years to 88 Years
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 4
States / cities: Hagerstown, Maryland • Minneapolis, Minnesota • Jackson, Mississippi + 1 more

Conditions: Pruritus, Atopic Dermatitis
Interventions: Aurstat Anti-Itch Hydrogel (Aurstat); Drug
Lead sponsor: The Center for Clinical and Cosmetic Research; Other
Eligibility: 12 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Aventura, Florida

Conditions: Hair Thinning
Interventions: Nutrafol Supplement Capsules, Placebo Capsules; Dietary Supplement · Other
Lead sponsor: Ablon Skin Institute Research Center; Other
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Manhattan Beach, California

Search by objective public record fields.

Brain Enhancement Training Towards Elders Resilience to Aging

Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR) Treatment Approach for Stroke

Infrared Camera for Brain Mapping During Surgery

Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral Dysfunction

Absorption, Metabolism, and Excretion Study of BIIB074

Variability in the Measurement of WBCT Between Blood Drawn From Indwelling Catheters and Direct Venipuncture

Radiofrequency Ablation of Papillary Thyroid Microcarcinoma

Randomized Trial Of Achieving Healthy Lifestyles In Psych Rehabilitation

Using Data From a Multisensor Rapid Health Assessment Device to Predict Decompensation in Long COVID (AIDI)

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause

The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)

An Online Trial of Five Well-being Programs

Adult Liver Transplant Enhanced Care

Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients

Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor

Combination Drug Therapy for Patients With Hepatitis C

Treatment Burden Screening Questionnaire Pilot Study

D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents

Applying a Case Management Model in a VA Homeless Program

Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability

ACHIEVE Hearing Intervention Follow-Up Study

Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus

Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Peri-menopausal and Menopausal Women With Thinning Hair